	Cutaneous melanoma histopathologic features and laboratory findings as predictors of sentinel lymph node status and progression-free survival: a single-center experience. Acta Dermatovenerol Alp Pannonica Adriat Panti, Pantovi, Kotur M, Petri, Radivojevi, Petrovi, Vujo, Gruji, Grozdi, , Artiko V, Odalovi. PMID: 41712199 [PubMed - indexed for MEDLINE]
	Correction to "Advances in the noninvasive diagnosis of melanoma-40 years beyond the ABCDs". CA Cancer J Clin PMID: 41711686 [PubMed - in process]
	SWE-NEO: Swedish NEO-adjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma: study protocol for a phase III open-label multi-centre trial. Acta Oncol Helgadottir H, Carneiro A, Portelli F, Papadakis K, Björkström K, Yang M, Johansson I, Skogvall Svensson I, Jazrawi A, Hallgren A, Harbst K, Bark R, Egyhazi Brage S, Berglund A, Isaksson K, Wickström S, Nilsson J, Ny L, Jönsson G, Olofsson Bagge R, SWE-NEO Study Group. PMID: 41711492 [PubMed - in process]
	Rational Design and Responsive Transdermal Cargo Delivery of Microneedles in the Treatment of Melanoma. Int J Nanomedicine Cai M, Jia Y, Fu T, Kong J, Qiu Y, Zhao Y, Li X, Yang Y, Bai D. PMID: 41710366 [PubMed - indexed for MEDLINE]
	Effective inhibition of lung metastatic melanoma by pH-responsive lipopeptide/PLGA hybrid nanoparticles silencing PD-L1 with augmented suppression of the AKT/Î²-catenin pathway. J Mater Chem B Yang Z, Wang S, Song Z, Guo R, Ding D, Gao Y, Qiao M. PMID: 41709848 [PubMed - as supplied by publisher]
	Tumour-infiltrating lymphocyte therapy in melanoma: ready for prime time? Br J Cancer Woodford R, Lorigan P, Oudit D, Abdulgawad A, Thistlethwaite F, Lim KHJ. PMID: 41708938 [PubMed - as supplied by publisher]
	Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB): A Translational Pharmacodynamic Biomarker for PIKfyve Inhibition With VRG50635. Clin Transl Sci Gontier G, Kim G, Wang C, Zhu K, Gau R, Zhang N, Naphade S, Stewart A, Schmidt MJ, Galemmo R, Shook B, Tarachandani A, Choi I, Raines S, Scannevin RH, Grievink HW, Smits LMG, Kremer PHC, Cadavid D. PMID: 41708347 [PubMed - indexed for MEDLINE]
	Tumor necrosis alpha inhibitor therapy is associated with increased long-term risk of non-melanoma skin cancer and melanoma: a retrospective cohort study. J Am Acad Dermatol Driscoll CB, Schwab G, Quan VL, McKenney J, Hooper MJ, Shankar Ramesh Kumar SK, Kundu RV, Kundu SD. PMID: 41707711 [PubMed - as supplied by publisher]
	Integrated LIBS-Raman spectroscopy coupled with explainable machine learning for biochemical characterization of melanoma. Spectrochim Acta A Mol Biomol Spectrosc Khan MN, Zhou Q, Guo J, Liu L, Hu R. PMID: 41707627 [PubMed - as supplied by publisher]
	[Utilization and diagnostic yield of the Fast-Track Referral Pathway for suspected melanoma: a six-year analysis]. Semergen Alonso-Chornet V, Armengot-Carbó M. PMID: 41707403 [PubMed - as supplied by publisher]
	Lamin B receptor upregulation in metastatic melanoma causes nuclear envelope fragility in confined migration during cancer invasion. Proc Natl Acad Sci U S A Baird MA, Jewett CE, Malide DA, Kratz L, Cartagena-Rivera AX, Fischer RS, Waterman CM. PMID: 41706894 [PubMed - indexed for MEDLINE]
	Mucosal Melanoma of Head and Neck: A Rare and Aggressive Disease-A Register-Based Cohort Study. J Oral Pathol Med Degerholm SC, Salo TA, Mauramo MO. PMID: 41704147 [PubMed - as supplied by publisher]
	Noninvasive skin imaging of melanocytic and nonmelanocytic tumours: recent findings. Curr Opin Oncol Boussingault L, Mtimet L, Suppa M. PMID: 41703997 [PubMed - indexed for MEDLINE]
	Melanoma in adolescents and young adults: special considerations. Curr Opin Oncol Abboud S, Romano L, Langouo Fontsa M. PMID: 41703996 [PubMed - indexed for MEDLINE]
	Clinical and Pathological Characteristics of Skin Cancer Patients at Southern Medical University, Guangzhou, China. Acta Derm Venereol Li S, Zou J, Chen R, Zhang L. PMID: 41703988 [PubMed - indexed for MEDLINE]
	Insurance, race, and socioeconomic disparities in systemic therapy receipt for melanoma in the United States: a systematic review. Melanoma Manag Zhang S, Hernandez RK, Cheek J, Aziz R, Vetter IL, Adamson AS. PMID: 41703897 [PubMed]
	I was the barrier: A patient's perspective on delayed diagnosis of malignant melanoma. Clin Exp Dermatol Hoban J, Leahy M, Byrne B, Lynch M, McKeown P. PMID: 41703785 [PubMed - as supplied by publisher]
	A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced cutaneous melanoma. Cancer Zakharia Y, Kim D, Freesmeier M, Frees M, Mott S, Monga V, Laux D, Javed A, Rieth J, Smestad J, Milhem M. PMID: 41701511 [PubMed - indexed for MEDLINE]
	Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open Leachman SA, Luke JJ, Ascierto PA, Long GV, Khattak MA, Rutkowski P, Xu ZJ, Fukunaga-Kalabis M, Krepler C, Eggermont AMM, Schadendorf D. PMID: 41701495 [PubMed - indexed for MEDLINE]
	Verhoeff-van Gieson May Distinguish Desmoplastic Melanoma From Re-Excision Scar. Am J Dermatopathol Kiszluk A, Alhalaseh YN, Asar MC, Chen F, Speiser JJ. PMID: 41700577 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 45172

Page 1 of 2259



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy